Please login to the form below

Not currently logged in
Email:
Password:

Handl Therapeutics

This page shows the latest Handl Therapeutics news and features for those working in and with pharma, biotech and healthcare.

UCB boosts gene therapy offering with a pair of new deals

UCB boosts gene therapy offering with a pair of new deals

Handl Therapeutics – based in Leuven, Belgium – specialises in adeno-associated virus (AAV) capsid technology and has a focus on developing disease modifying gene therapies to treat neurodegenerative diseases. ... the development of gene therapies

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...

Latest intelligence

Patient Clinical Trial & Communications Plan Review: A Customer Story
...
Working together to achieve better patient pathways
Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
Design-thinking. Iterating for continuous improvement.
How design can lead improvement within Pharma...